Jane Street’s Oragenics OGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.41K Buy
+12,771
New +$7.76K ﹤0.01% 11328
2022
Q4
Sell
-32
Closed -$13K 9825
2022
Q3
$13K Buy
32
+12
+60% +$7.01K ﹤0.01% 9293
2022
Q2
$12K Sell
20
-8
-29% -$4.62K ﹤0.01% 9279
2022
Q1
$17K Buy
28
+9
+47% +$6.6K ﹤0.01% 9978
2021
Q4
$15K Sell
19
-12
-39% -$12.1K ﹤0.01% 9851
2021
Q3
$35K Buy
+31
New +$37.4K ﹤0.01% 9643
2021
Q2
Sell
-18
Closed -$30K 10215
2021
Q1
$30K Buy
+18
New +$32.7K ﹤0.01% 8931

Other funds holding OGEN

Jane Street's OGEN Position: Q2 2026 in Review

Jane Street opened a new position in Oragenics (OGEN) in Q2 2026: 12,771 shares worth $7.41K. The stake represents ﹤0.01% of the portfolio and ranks #11328 among its holdings. This is a return to the name: Jane Street previously reported a position in OGEN as recently as Q3 2022.

Jane Street first reported a position in OGEN in Q1 2021 and has held it in 7 quarters since. The position peaked at $35K in Q3 2021. 17 funds tracked by Wall St. Rank hold OGEN as of Q2 2026.

  • Jane Street held 12,771 shares of Oragenics worth $7.41K as of Q2 2026.
  • Oragenics was a new Jane Street position in Q2 2026.
  • Oragenics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #11328 holding.
  • Jane Street first reported a position in Oragenics in Q1 2021 and has held it in 7 quarters since.
  • Jane Street's Oragenics position peaked at $35K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held Oragenics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.